Hematopoietic Effect of Amaranthus cruentus Extract on Cyclophosphamide Induced Toxicity in Rats

groupview

Abstract
Pharmacognosy Communications,2019,9,4,139-142.
Published:September 2019
Type:Original Article

Hematopoietic Effect of Amaranthus cruentus Extract on Cyclophosphamide Induced Toxicity in Rats

Stuti Pandey, Aditya Ganeshpurkar*, Nazneen Dubey

Shri Ram Institute of Technology-Pharmacy, Jabalpur, Madhya Pradesh, INDIA.

Abstract:

Introduction: Amaranthus cruentus (Amaranthaceae) is one of the popularly grown leafy vegetables in the Indian subcontinent. The leaves of the plant are rich in polyphenols, tannins, flavonoids, steroids, terpenoids, saponins and betalains. The plant is also rich in protein, calcium, iron, as well as vitamins A, E, C and folic acid. The present work was undertaken to evaluate the anti-anemic effects of Amaranthus cruentus. Methods: An ethanol extract of Amaranthus cruentus was prepared and the of folic acid, ascorbic acid, iron, polyphenol and flavonoid contents were estimated. Acute oral toxicity of the extract was determined according to OECD guideline-423 at doses of 200 mg/kg and 400 mg/kg. Cyclophosphamide (0.3 mg/kg, i.p.) was used to induce anemia in rats. After anemia induction, animals were treated with standard preparation (Ferritop Syrup) and the extract. Results: Amaranthus cruentus extract significantly aided to restore the levels of RBCs, WBCs, hemoglobin and increased hematocrit levels. Conclusion: Thus, it was concluded that Amaranthus cruentus is a rich source of phytochemicals that demonstrate hematopoietic effects.

Cite This Article

Founded:  In 2004, as the PHCOG.NET – a non-profit private organization dedicated to Natural Products Research leading to develop promising drugs. Our main mission is to make information on herbal drug research readily available in different formats to suit the individual needs.

Pharmacognosy Communications [Phcog Commn.] is a new quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the  publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.

The journal aims to cater the latest outstanding developments in the field of pharmacognosy and natural products and drug design covering but not limited to the following topics:

  • Pharmacognosy and pharmacognistic investigations
  • Research based ethnopharmacological evaluations
  • Biological evaluation of crude extracts, essential oils and pure isolates
  • Natural product discovery and evaluation
  • Mechanistic studies
  • Method and technique development and evaluation
  • Isolation, identification and structural elucidation of natural products
  • Synthesis and transformation studies

Distinctions:  The most widely read, cited, and known Pharmacognosy Communications and website is well browsed with all the articles published. More than 20,000 readers in nearly every country in the world each month

Aim and Scope | Editorial Board | Indexed & Abstracted | Instruction to Authors | Manuscript Submission & Charges

Subjects Covered : Natural Products, Pharmacognosy, Phytochemistry, Marine Pharmacognosy and Zoo Pharmacognosy
ISSN :2249-0159 (Print) ; 2249-0167 (Online) Frequency : Quarterly Rapid at a time publication (4 issues/year)

Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online  publication is 45 days.
Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.